Fresh from a $105 million third-round financing earlier this month, ALX Oncology has won two FDA fast-track designations for its lead immuno-oncology drug. The Irish-American biotech picked up the ...

PARAMUS, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) today announced that its Board of Directors has declared a regular quarterly dividend of $4.50 per share payable ...

ALX held total debt of $988 million as of the end of its fourth quarter. The $300 million of debt held on 731 Lexington retail is also held at a ZIRP era rate of interest at 1.76%. While ALX ...